Literature DB >> 1425018

The molecular biology of interleukin 6 and its receptor.

T Kishimoto1, M Hibi, M Murakami, M Narazaki, M Saito, T Taga.   

Abstract

Functional pleiotropy and redundancy are characteristic features of cytokines. Interleukin 6 (IL-6) is a typical example: IL-6 induces cellular differentiation or expression of tissue-specific genes; it is involved in processes such as antibody production in B cells, acute-phase protein synthesis in hepatocytes, megakaryocyte maturation, cytotoxic T cell differentiation, and neural differentiation of PC12 (pheochromocytoma) cells. It promotes growth of myeloma/plasmacytoma cells, T cells, keratinocytes and renal mesangial cells, and it inhibits growth of myeloid leukaemic cell lines and certain carcinoma cell lines. The IL-6 receptor consists of two polypeptide chains, a ligand-binding chain (IL-6R) and a non-ligand-binding, signal-transducing chain (gp130). Interaction of IL-6 with IL-6R triggers the association of gp130 and IL-6R, and the signal can be transduced through gp130. Association of gp130 with IL-6R is involved in the formation of high affinity binding sites. This two-chain model has been shown to be applicable to receptor systems for several other cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3, IL-5 and nerve growth factor (NGF). The pleiotropy and redundancy of cytokines may be explained on the basis of this unique receptor system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425018     DOI: 10.1002/9780470514269.ch2

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  20 in total

1.  Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody.

Authors:  J Ogawa; M Harigai; T Akashi; K Nagasaka; F Suzuki; S Tominaga; N Miyasaka
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

Authors:  Andrew L Croxford; Susanne Karbach; Florian C Kurschus; Simone Wörtge; Alexei Nikolaev; Nir Yogev; Sabrina Klebow; Rebecca Schüler; Sonja Reissig; Carolin Piotrowski; Elke Brylla; Ingo Bechmann; Jürgen Scheller; Stefan Rose-John; F Thomas Wunderlich; Thomas Münzel; Esther von Stebut; Ari Waisman
Journal:  J Invest Dermatol       Date:  2013-09-25       Impact factor: 8.551

3.  The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Alvise Berti; Roscoe Warner; Kent Johnson; Divi Cornec; Darrell R Schroeder; Brian F Kabat; Carol A Langford; Cees G M Kallenberg; Philip Seo; Robert F Spiera; E William St Clair; Fernando C Fervenza; John H Stone; Paul A Monach; Ulrich Specks; Peter A Merkel
Journal:  J Autoimmun       Date:  2019-07-15       Impact factor: 7.094

4.  Ectopic hormone-secreting pheochromocytoma: a francophone observational study.

Authors:  James Kirkby-Bott; Laurent Brunaud; Muriel Mathonet; Etienne Hamoir; Jean-Louis Kraimps; Christophe Trésallet; Laurence Amar; Alexandre Rault; Jean-Francois Henry; Bruno Carnaille
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 5.  Tumor necrosis factor-associated periodic syndrome in adults.

Authors:  Sharika Gopakumar Menon; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-09-23       Impact factor: 2.631

6.  A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis.

Authors:  Guoliang Zhang; Boping Zhou; Wenfei Wang; Mingxia Zhang; Yahua Zhao; Zheng Wang; Lin Yang; Jingnan Zhai; Carl G Feng; Junwen Wang; Xinchun Chen
Journal:  J Infect Dis       Date:  2012-03-28       Impact factor: 5.226

7.  An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome.

Authors:  Edi Vaisbuch; Roberto Romero; Ricardo Gomez; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08-11

8.  Endotoxin-Induced IL-6 Promoter Activation in Skeletal Muscle Requires an NF-κB Site.

Authors:  David Yeagley; Charles H Lang
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2010-01-01

Review 9.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

10.  Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women.

Authors:  Anna Nordström; Paul Gerdhem; Helena Brändström; Fredrik Stiger; Ulf H Lerner; Mattias Lorentzon; Karl Obrant; Peter Nordström; Kristina Akesson
Journal:  Osteoporos Int       Date:  2004-03-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.